Uptake and metabolism of the new anticancer compound β-L-(-)-dioxolane- cytidine in human prostate carcinoma DU-145 cells

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4187-4191

  Grove, Kristie L ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CYTARABINE; CYTIDINE DERIVATIVE; DIOXOLANE CYTIDINE; DNA FRAGMENT; DRUG METABOLITE; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG RETENTION; DRUG TRANSPORT; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR XENOGRAFT;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CELL LINE; CYTARABINE; CYTOSINE; DIOXOLANES; DNA, NEOPLASM; HUMANS; KINETICS; MALE; PROSTATIC NEOPLASMS; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0029836284     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bridges, E. G., and Cheng, Y-C. Use of novel β-L-nucleoside analogs for treatment and prevention of chronic hepatitis B virus and hepatocellular carcinoma. Prog. Liver Dis., 9. 231-45, 1995.
2. Larder, B. A., Kemp, S. D., and Harrigan, P. R Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science (Washington DC), 269 696-699, 1995.
3. Bridges, E G., Dutschman, G. E , Gullen, E. A., and Cheng, Y. C. Favorable interaction of β-L-(-)-nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus. Biochem Pharmacol., 51: 753-736, 1996.
4. Grove, K. L , Quo, X , Liu, S-H., Gao, Z , Chu, C. K., and Cheng, Y-C. Anti-cancer activity of β-L-(-)-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L-configuration. Cancer Res., 55; 3008-3011, 1995.
5. Kukhanova, M., Liu, S-H., Mozzherin, D , Lin, T-S., Chu, C. K., and Cheng, Y. C L- and D-enantiomers of 2′,3′-dideoxycylidine-5′-triphosphate analogs as substrates for human DNA polymerases. J. Biol. Chem., 270: 23055-23059, 1995
6. Plagemann, P. G. W., Marz, R , and Wohlhuerter, R M. Transport and metabolism of deoxycytidine and 1-β-D-arabinofuranosylcytosine in cultured Novikoff rat hepatoma cells, relationship to phosphorylation and regulation of triphosphate synthesis. Cancer Res., 38: 978-989, 1978.
7. Wiley, J. S., Taupin, J , Jamieson, G P., Snook, M., Sawyer, W H., and Finch, L. R. Cytosine arabinoside transport and metabolism in acute leukemia and acute lymphoblastic lymphoma. J Clin. Invest., 75: 632-642, 1985
8. White, J C., Rathmell, J P , and Capizzi, R L. Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemic cells J. Clin. Invest., 79: 380-387, 1987.
9. Heinemann, V , Hertel, L. W , Grindey, G. B., and Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosyl-cytosine. Cancer Res., 48 4024-4031, 1988.
10. Rustum, Y. M , and Preisler, H. D. Correlation between leukemic cell retention of 1-β-D-arabinofuranosylcytosine-5′-triphosphate and response to therapy Cancer Res., 39: 42-49, 1979.
11. Kubota, M , Takimoto, T., Kitoh, T., Tanizawa, A., Kiriyama, Y , Akiyama, Y., and Mikawa, H. Prevention of 1-β-D-arabinofuranosylcytosine toxicity by 4-nitrobenzyl-6-thiomosine or dipyridamole in leukemic cell lines Anticancer Res., 8: 339-342, 1988
12. Plagemann, P. G. W., Wohlhueter, M., and Woffendin, C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys. Acta, 947: 405-443, 1988
13. Domin, B. A., Mahony, W. B., and Zimmerman, T. P. Membrane permeation mechanisms of 2′,3′-dideoxynucleosides. Biochem. Pharmacol., 46: 725-729, 1993
14. Mahony, W. B., Domin, B A., Daluge, S. M., Miller, W. H., and Zimmerman, T. P. Enantiomeric selectivity of carbovir transport. J. Biol. Chem., 267: 19792-19797, 1992
15. Chen, H X., Bamberger, U., Heckel, A., Guo, X., and Cheng, Y-c. BIBW 22, a dipyndamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport. Cancer Res., 53: 1974-1977, 1993.
16. Finlay, G J., Baguley, B. C., and Wilson, W R. A semiautomated microculture method for investigating exponentially growing carcinoma cells. Anal. Biochem., 139: 272-277, 1984.
17. Ohno, Y., Spriggs, D , Matsukage, A , Ohno, T., and Kufe, D. Sequence-specific inhibition of DNA strand elongation by incorporation of 9-β-D-arabinofuranosyladenine. Cancer Res., 49: 2077-2081, 1989.
18. Belt, J. A., Marina, N M., Phelps, D. A., and Crawford, C. R. Nucleoside transport in normal and neoplastic cells. Adv. Enzyme Regul., 33: 235-252, 1993.
19. Chang, C-N., Skalski, V., Zhou, J. H , and Cheng, Y C. Biochemical pharmacology of (+) and (-)-2′,3′-dideoxy-3′-thracytidine as anti hepatitis B virus agents. J. Biol. Chem , 267: 22414-22420, 1992.
20. Paff, M. T , Auerett, D R., Prus, K. L., Miller, W. H., and Nelson, D J. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine in HepG2 derivative 22.15 (subclone P5A) cells. Antimicrob. Agents Chem., 38: 1230-1238, 1994.
21. Heinemann, V., Xu, Y-Z., Chubb, S., Sen, A , Hertel, L. W., Grindey, G. B., and Plunkett, W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine Mol. Pharmacol., 38: 567-572, 1990.
22. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage inhuman acute my-elogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989
23. Huang, P , and Plunkett, W. Fludarabine and gemcitabine-induced apoptosis. incorporation of analogs into DNA is a critical event Cancer Chemother. Pharmacol., 36: 181-188, 1995.
24. Kizaki, H , Ohnishi, Y., Azuma, Y., Mizuma, Y , and Oshaka, F. 1-β-D-arabinosyl-cytosine and 5-azacytidine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology, 24: 219-227, 1992.
25. Cohen, G. M., Sun, X M., Snowden, R. T., Dinsdale, D , and Skilleter, D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J , 286. 331-334, 1992.
26. Catchpoole, D. R , and Stewart, B W. Etoposide-induced cytotoxicity in two human T-cell leukemic lines delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res., 53: 4287-4296, 1993
27. Rusnak, J M., Calmels, T. P G , Hoyt, D. G , Kondo, Y., Yalowich, J. C , and Lazo, J. S. Genesis of discrete higher order DNA fragments in apoptotic human prostatic carcinoma cells Mol Pharmacol , 49. 244-252, 1996.